Clinical Trial

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-29 -> 2026-12-31 2026-08-04
minor Completion pushed: 2026-12-31 -> 2027-06-30 2026-08-04
Trial Details
NCT Number NCT06096688
Lead Sponsor Weill Medical College of Cornell University
Collaborators: National Cancer Institute (NCI)
Conditions Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes
Enrollment 1,120 participants
Start Date 2019-05-29
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-03